Related Experiment Videos
Zirconium compound-induced pulmonary fibrosis
T Bartter1, R S Irwin, J L Abraham
1Division of Pulmonary and Critical Care Medicine, Cooper Hospital, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Camden.
Archives of Internal Medicine
|June 1, 1991
Summary
Inhalation of zirconium compounds may cause pulmonary fibrosis in humans, a condition known as zirconium pneumoconiosis. This study documents a likely case, highlighting the need for workplace safety precautions.
Area of Science:
- Occupational Medicine
- Pulmonary Medicine
- Toxicology
Background:
- Human pulmonary disease linked to zirconium inhalation has been suspected but poorly documented.
- Zirconium pneumoconiosis, a specific type of lung disease caused by zirconium exposure, lacks substantial human case studies.
Observation:
- A patient presented with progressive pulmonary fibrosis and dyspnea after a 15-year latency period following zirconium exposure.
- Chest roentgenograms showed fibrosis consistent with pneumoconiosis.
- Open lung biopsy revealed end-stage fibrosis, honeycombing, birefringent particles, and exceptionally high levels of zirconium compounds.
Findings:
- The case presented strong evidence of zirconium compound-induced pulmonary fibrosis.
- Analysis of lung biopsy confirmed the presence of significant zirconium accumulation.
- No alternative causes for the observed pulmonary fibrosis were identified.
Implications:
- Zirconium should be recognized as a potential cause of occupational lung disease (pneumoconiosis).
- Implementing stringent workplace safety measures is crucial to prevent zirconium exposure and subsequent pulmonary disease.
- Further research into zirconium toxicity and prevention strategies is warranted.